SCHEMBL6987915

SCHEMBL6987915

CC(C)(C)OC(=O)NCCOc1noc2ccc(OC(F)F)cc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 5/20 0.47
CA1 P00915 5/20 0.47
CA2 P00918 5/20 0.47
CA9 Q16790 5/20 0.47
PDK2 Q15119 1/20 0.42
BCHE P06276 1/20 0.41
CNR2 P34972 1/20 0.41
CYP1A1 P04798 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2B6 P20813 1/20 0.39
CYP2C19 P33261 1/20 0.39
CYP3A43 Q9HB55 1/20 0.39
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
GLA P06280 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
HPGD P15428 1/20 0.38
HIF1A Q16665 1/20 0.38
SCN9A Q15858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6991751 0.90 CA12 (0.50) CA12CA1CA2CA9PDK2
SCHEMBL6990451 0.87 CA12 (0.47) CA12CA1CA2CA9PDK2
SCHEMBL6990907 0.85 CA12 (0.45) CA12CA1CA2CA9PDK2
SCHEMBL6989190 0.84 NQO2 (0.48) CA12CA1CA2CA9PDK2
SCHEMBL6993977 0.84 CA12 (0.46) CA12CA1CA2CA9PDK2
SCHEMBL6987623 0.83 CA12 (0.45) CA12CA1CA2CA9PDK2
SCHEMBL6992047 0.83 CA12 (0.47) CA12CA1CA2CA9PDK2
SCHEMBL6989587 0.83 FAAH (0.49) CA12CA1CA2CA9BCHE
SCHEMBL6990569 0.82 CA12 (0.44) CA12CA1CA2CA9PDK2
SCHEMBL6987842 0.82 CA1 (0.44) CA12CA1CA2CA9PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0779281-B1 ISOXAZOLES SANKYO CO (JP) 2003-10-29 EP disclosed
US-6096771-A ISOXAZOLE DERIVATIVES EXHIBITING EXCELLENT TYPE B AND TYPE A MONOAMINE OXIDASE INHIBITORY ACTIVITIES, THEREFORE USEFUL FOR PREVENTING PARKINSON'S DISEASE, DEPRESSION AND ALZHEIMER'S DISEASE SANKYO COMPANY, LIMITED (JP) 2000-08-01 US disclosed
US-5965591-A MONOAMINE OXIDASE INHIBITOR; FOR PROPHYLAXIS AND TREATING PARKINSON'S DISEASE, DEPRESSION AND ALZHEIMER'S DISEASE SANKYO COMPANY, LIMITED (JP) 1999-10-12 US disclosed
EP-0779281-A1 ISOXAZOLES SANKYO COMPANY LIMITED (JP) 1997-06-18 EP disclosed